Symbol:
Sema4g
Name:
semaphorin 4G
RGD ID:
1310436
Description:
Predicted to enable chemorepellent activity; neuropilin binding activity; and semaphorin receptor binding activity. Predicted to be involved in several processes, including axon guidance; neural crest cell migration; and semaphorin-plexin signaling pathway. Predicted to be active in plasma membrane. Orthologous to human SEMA4G (semaphorin 4G); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC361764; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; semaphorin-4G
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SEMA4G (semaphorin 4G)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Sema4g (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Sema4g (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SEMA4G (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SEMA4G (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Sema4g (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SEMA4G (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SEMA4G (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Sema4g (semaphorin 4G)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
B3GNTL1 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
SEMA4G (semaphorin 4G)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Sema4g (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
sema4ga (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Ga)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
sema4gb (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Gb)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Sema2a
Alliance
DIOPT (Ensembl Compara|OrthoInspector|PANTHER)
Caenorhabditis elegans (roundworm):
smp-1
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
sema4g
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 253,799,552 - 253,814,504 (+) NCBI GRCr8 mRatBN7.2 1 243,849,979 - 243,865,343 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 243,853,854 - 243,865,341 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 252,001,505 - 252,013,024 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 258,699,388 - 258,710,907 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 251,351,556 - 251,363,041 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 264,738,935 - 264,753,399 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 264,741,911 - 264,753,397 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 272,181,343 - 272,195,787 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 250,057,504 - 250,068,990 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 250,315,156 - 250,329,560 (+) NCBI Celera 1 239,665,332 - 239,676,819 (+) NCBI Celera Cytogenetic Map 1 q54 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Sema4g Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SEMA4G mRNA] CTD PMID:31150632 Sema4g Rat 1,2-dimethylhydrazine decreases expression ISO Sema4g (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SEMA4G mRNA CTD PMID:22206623 Sema4g Rat 1,2-dimethylhydrazine multiple interactions ISO Sema4g (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4G mRNA CTD PMID:22206623 Sema4g Rat 17beta-estradiol decreases expression ISO SEMA4G (Homo sapiens) 6480464 Estradiol results in decreased expression of SEMA4G mRNA CTD PMID:20106945 Sema4g Rat 17beta-estradiol decreases expression ISO Sema4g (Mus musculus) 6480464 Estradiol results in decreased expression of SEMA4G mRNA CTD PMID:39298647 Sema4g Rat 2,2',5,5'-tetrachlorobiphenyl increases expression ISO SEMA4G (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SEMA4G mRNA CTD PMID:22298810 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Sema4g (Mus musculus) 6480464 [Tetrachlorodibenzodioxin affects the methylation of SEMA4G promoter] which results in decreased expression of SEMA4G mRNA CTD PMID:33017471 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SEMA4G mRNA CTD PMID:32109520 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Sema4g (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SEMA4G mRNA CTD PMID:19770486 and PMID:26290441 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sema4g (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SEMA4G mRNA CTD PMID:26377647 Sema4g Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SEMA4G mRNA CTD PMID:21215274 and PMID:33387578 Sema4g Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Sema4g (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Sema4g Rat 2-hydroxypropanoic acid decreases expression ISO SEMA4G (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SEMA4G mRNA CTD PMID:30851411 Sema4g Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SEMA4G (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SEMA4G mRNA CTD PMID:28628672 Sema4g Rat 4,4'-sulfonyldiphenol multiple interactions ISO SEMA4G (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SEMA4G mRNA CTD PMID:28628672 Sema4g Rat 4,4'-sulfonyldiphenol decreases methylation ISO Sema4g (Mus musculus) 6480464 bisphenol S results in decreased methylation of SEMA4G exon CTD PMID:33297965 Sema4g Rat 4,4'-sulfonyldiphenol affects expression ISO Sema4g (Mus musculus) 6480464 bisphenol S affects the expression of SEMA4G mRNA CTD PMID:39298647 Sema4g Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SEMA4G mRNA CTD PMID:24780913 Sema4g Rat acrylamide decreases expression ISO SEMA4G (Homo sapiens) 6480464 Acrylamide results in decreased expression of SEMA4G mRNA CTD PMID:32763439 Sema4g Rat aflatoxin B1 affects expression ISO SEMA4G (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SEMA4G protein CTD PMID:20106945 Sema4g Rat aflatoxin B1 decreases expression ISO SEMA4G (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SEMA4G mRNA CTD PMID:27153756 Sema4g Rat aflatoxin B1 decreases methylation ISO SEMA4G (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SEMA4G gene CTD PMID:27153756 Sema4g Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEMA4G mRNA CTD PMID:35163327 Sema4g Rat aristolochic acid A increases expression ISO SEMA4G (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SEMA4G mRNA CTD PMID:33212167 Sema4g Rat arsane decreases methylation ISO SEMA4G (Homo sapiens) 6480464 Arsenic results in decreased methylation of SEMA4G gene CTD PMID:31135185 Sema4g Rat arsenic atom decreases methylation ISO SEMA4G (Homo sapiens) 6480464 Arsenic results in decreased methylation of SEMA4G gene CTD PMID:31135185 Sema4g Rat arsenite(3-) decreases expression ISO Sema4g (Mus musculus) 6480464 arsenite results in decreased expression of SEMA4G mRNA CTD PMID:33053406 Sema4g Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SEMA4G mRNA CTD PMID:36841081 Sema4g Rat benzo[a]pyrene increases methylation ISO SEMA4G (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SEMA4G 5' UTR and Benzo(a)pyrene results in increased methylation of SEMA4G promoter CTD PMID:27901495 Sema4g Rat benzo[a]pyrene decreases expression ISO SEMA4G (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SEMA4G mRNA CTD PMID:32234424 Sema4g Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SEMA4G mRNA CTD PMID:25181051 and PMID:30903817 Sema4g Rat bisphenol A decreases expression ISO Sema4g (Mus musculus) 6480464 bisphenol A results in decreased expression of SEMA4G mRNA CTD PMID:32156529 Sema4g Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SEMA4G mRNA CTD PMID:34947998 Sema4g Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SEMA4G mRNA CTD PMID:32145629 Sema4g Rat bisphenol A increases expression ISO Sema4g (Mus musculus) 6480464 bisphenol A results in increased expression of SEMA4G mRNA CTD PMID:29165653 and PMID:34585602 Sema4g Rat bisphenol A affects expression ISO SEMA4G (Homo sapiens) 6480464 bisphenol A affects the expression of SEMA4G mRNA CTD PMID:30903817 Sema4g Rat bisphenol F decreases expression ISO Sema4g (Mus musculus) 6480464 bisphenol F results in decreased expression of SEMA4G mRNA CTD PMID:38685157 Sema4g Rat buta-1,3-diene decreases expression ISO Sema4g (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SEMA4G mRNA CTD PMID:29038090 Sema4g Rat caffeine decreases phosphorylation ISO SEMA4G (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of SEMA4G protein CTD PMID:35688186 Sema4g Rat carbon nanotube decreases expression ISO Sema4g (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of SEMA4G mRNA CTD PMID:25620056 Sema4g Rat CGP 52608 multiple interactions ISO SEMA4G (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SEMA4G gene] CTD PMID:28238834 Sema4g Rat chlorpyrifos increases expression ISO Sema4g (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SEMA4G mRNA CTD PMID:20350560 Sema4g Rat cisplatin multiple interactions ISO SEMA4G (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SEMA4G mRNA CTD PMID:27392435 Sema4g Rat cobalt dichloride decreases expression ISO SEMA4G (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of SEMA4G mRNA CTD PMID:19376846 Sema4g Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SEMA4G mRNA CTD PMID:24386269 Sema4g Rat cocaine affects expression EXP 6480464 Cocaine affects the expression of SEMA4G mRNA CTD PMID:15691709 Sema4g Rat copper(II) sulfate decreases expression ISO SEMA4G (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of SEMA4G mRNA CTD PMID:19549813 Sema4g Rat crocidolite asbestos increases expression ISO Sema4g (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of SEMA4G mRNA CTD PMID:29279043 Sema4g Rat cyclosporin A decreases expression ISO SEMA4G (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SEMA4G mRNA CTD PMID:20106945 and PMID:25562108 Sema4g Rat dexamethasone multiple interactions ISO SEMA4G (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SEMA4G mRNA CTD PMID:28628672 Sema4g Rat Dibutyl phosphate affects expression ISO SEMA4G (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SEMA4G mRNA CTD PMID:37042841 Sema4g Rat dicrotophos increases expression ISO SEMA4G (Homo sapiens) 6480464 dicrotophos results in increased expression of SEMA4G mRNA CTD PMID:28302478 Sema4g Rat diethyl malate affects expression ISO Sema4g (Mus musculus) 6480464 diethyl malate affects the expression of SEMA4G mRNA CTD PMID:24814887 Sema4g Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SEMA4G mRNA CTD PMID:29391264 Sema4g Rat fenthion increases expression ISO Sema4g (Mus musculus) 6480464 Fenthion results in increased expression of SEMA4G mRNA CTD PMID:34813904 Sema4g Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SEMA4G mRNA CTD PMID:24136188 Sema4g Rat folic acid multiple interactions ISO Sema4g (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4G mRNA CTD PMID:22206623 Sema4g Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SEMA4G mRNA CTD PMID:33387578 Sema4g Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SEMA4G mRNA CTD PMID:24136188 Sema4g Rat GW 4064 increases expression ISO Sema4g (Mus musculus) 6480464 GW 4064 results in increased expression of SEMA4G mRNA CTD PMID:26655953 Sema4g Rat hydrogen peroxide affects expression ISO SEMA4G (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SEMA4G mRNA CTD PMID:20044591 Sema4g Rat indometacin multiple interactions ISO SEMA4G (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SEMA4G mRNA CTD PMID:28628672 Sema4g Rat inulin multiple interactions ISO Sema4g (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEMA4G mRNA CTD PMID:36331819 Sema4g Rat lead(0) affects expression ISO SEMA4G (Homo sapiens) 6480464 Lead affects the expression of SEMA4G mRNA CTD PMID:28903495 Sema4g Rat menadione affects expression ISO SEMA4G (Homo sapiens) 6480464 Vitamin K 3 affects the expression of SEMA4G mRNA CTD PMID:20044591 Sema4g Rat methidathion increases expression ISO Sema4g (Mus musculus) 6480464 methidathion results in increased expression of SEMA4G mRNA CTD PMID:34813904 Sema4g Rat mono(2-ethylhexyl) phthalate decreases expression ISO Sema4g (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SEMA4G mRNA CTD PMID:22401849 Sema4g Rat nickel atom decreases expression ISO SEMA4G (Homo sapiens) 6480464 Nickel results in decreased expression of SEMA4G mRNA CTD PMID:24768652 and PMID:25583101 Sema4g Rat ozone multiple interactions ISO Sema4g (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SEMA4G mRNA CTD PMID:34911549 Sema4g Rat paracetamol affects expression ISO Sema4g (Mus musculus) 6480464 Acetaminophen affects the expression of SEMA4G mRNA CTD PMID:17562736 Sema4g Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SEMA4G mRNA CTD PMID:33387578 Sema4g Rat paracetamol decreases expression ISO SEMA4G (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SEMA4G mRNA CTD PMID:29067470 Sema4g Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of SEMA4G mRNA CTD PMID:32680482 Sema4g Rat perfluorononanoic acid decreases expression ISO SEMA4G (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SEMA4G mRNA CTD PMID:32588087 Sema4g Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Sema4g (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEMA4G mRNA CTD PMID:36331819 Sema4g Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEMA4G mRNA CTD PMID:35163327 Sema4g Rat pirinixic acid decreases expression ISO Sema4g (Mus musculus) 6480464 pirinixic acid results in decreased expression of SEMA4G mRNA CTD PMID:18445702 Sema4g Rat quercetin decreases expression ISO SEMA4G (Homo sapiens) 6480464 Quercetin results in decreased expression of SEMA4G mRNA CTD PMID:21632981 Sema4g Rat rac-lactic acid decreases expression ISO SEMA4G (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SEMA4G mRNA CTD PMID:30851411 Sema4g Rat silicon dioxide decreases expression ISO SEMA4G (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SEMA4G mRNA CTD PMID:25895662 Sema4g Rat silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SEMA4G mRNA CTD PMID:32721576 Sema4g Rat silver atom increases expression ISO Sema4g (Mus musculus) 6480464 Silver results in increased expression of SEMA4G mRNA CTD PMID:27131904 Sema4g Rat silver(0) increases expression ISO Sema4g (Mus musculus) 6480464 Silver results in increased expression of SEMA4G mRNA CTD PMID:27131904 Sema4g Rat sodium arsenite decreases expression ISO SEMA4G (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SEMA4G mRNA CTD PMID:29301061 Sema4g Rat succimer multiple interactions ISO Sema4g (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4G mRNA CTD PMID:21641980 Sema4g Rat tetrachloromethane decreases expression ISO Sema4g (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SEMA4G mRNA CTD PMID:27339419 and PMID:31919559 Sema4g Rat tetrachloromethane increases methylation EXP 6480464 Carbon Tetrachloride results in increased methylation of SEMA4G promoter CTD PMID:30690589 Sema4g Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SEMA4G mRNA CTD PMID:30690589 and PMID:31150632 Sema4g Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SEMA4G mRNA] CTD PMID:31150632 Sema4g Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SEMA4G mRNA CTD PMID:34492290 Sema4g Rat thiram decreases expression ISO SEMA4G (Homo sapiens) 6480464 Thiram results in decreased expression of SEMA4G mRNA CTD PMID:38568856 Sema4g Rat titanium dioxide decreases methylation ISO Sema4g (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SEMA4G gene and titanium dioxide results in decreased methylation of SEMA4G promoter CTD PMID:35295148 Sema4g Rat triphenyl phosphate affects expression ISO SEMA4G (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SEMA4G mRNA CTD PMID:37042841 Sema4g Rat triptonide decreases expression ISO Sema4g (Mus musculus) 6480464 triptonide results in decreased expression of SEMA4G mRNA CTD PMID:33045310 Sema4g Rat urethane decreases expression ISO SEMA4G (Homo sapiens) 6480464 Urethane results in decreased expression of SEMA4G mRNA CTD PMID:28818685 Sema4g Rat valproic acid increases methylation ISO SEMA4G (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SEMA4G gene CTD PMID:29154799 Sema4g Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SEMA4G mRNA CTD PMID:33150595 Sema4g Rat valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of SEMA4G promoter CTD PMID:33150595 Sema4g Rat vancomycin increases expression ISO Sema4g (Mus musculus) 6480464 Vancomycin results in increased expression of SEMA4G mRNA CTD PMID:18930951
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2-hydroxypropanoic acid (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (ISO) aflatoxin B1 (ISO) alpha-Zearalanol (EXP) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) atrazine (EXP) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) buta-1,3-diene (ISO) caffeine (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) cisplatin (ISO) cobalt dichloride (EXP,ISO) cocaine (EXP) copper(II) sulfate (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dicrotophos (ISO) diethyl malate (ISO) endosulfan (EXP) fenthion (ISO) flutamide (EXP) folic acid (ISO) gentamycin (EXP) glafenine (EXP) GW 4064 (ISO) hydrogen peroxide (ISO) indometacin (ISO) inulin (ISO) lead(0) (ISO) menadione (ISO) methidathion (ISO) mono(2-ethylhexyl) phthalate (ISO) nickel atom (ISO) ozone (ISO) paracetamol (EXP,ISO) paraquat (EXP) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) pirinixic acid (ISO) quercetin (ISO) rac-lactic acid (ISO) silicon dioxide (EXP,ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) succimer (ISO) tetrachloromethane (EXP,ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) triphenyl phosphate (ISO) triptonide (ISO) urethane (ISO) valproic acid (EXP,ISO) vancomycin (ISO)
Sema4g (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 253,799,552 - 253,814,504 (+) NCBI GRCr8 mRatBN7.2 1 243,849,979 - 243,865,343 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 243,853,854 - 243,865,341 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 252,001,505 - 252,013,024 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 258,699,388 - 258,710,907 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 251,351,556 - 251,363,041 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 264,738,935 - 264,753,399 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 264,741,911 - 264,753,397 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 272,181,343 - 272,195,787 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 250,057,504 - 250,068,990 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 250,315,156 - 250,329,560 (+) NCBI Celera 1 239,665,332 - 239,676,819 (+) NCBI Celera Cytogenetic Map 1 q54 NCBI
SEMA4G (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 100,969,504 - 100,985,616 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 100,969,504 - 100,985,871 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 10 102,729,261 - 102,745,373 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 102,722,276 - 102,735,362 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 10 102,722,275 - 102,735,362 NCBI Celera 10 96,470,007 - 96,483,094 (+) NCBI Celera Cytogenetic Map 10 q24.31 NCBI HuRef 10 96,361,299 - 96,374,700 (+) NCBI HuRef CHM1_1 10 103,016,494 - 103,029,583 (+) NCBI CHM1_1 T2T-CHM13v2.0 10 101,852,879 - 101,868,991 (+) NCBI T2T-CHM13v2.0
Sema4g (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 19 44,976,838 - 44,991,836 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 19 44,977,540 - 44,991,836 (+) Ensembl GRCm39 Ensembl GRCm38 19 44,988,743 - 45,003,397 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 19 44,989,101 - 45,003,397 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 19 45,063,834 - 45,077,885 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 19 45,042,655 - 45,056,706 (+) NCBI MGSCv36 mm8 Celera 19 45,759,978 - 45,774,039 (+) NCBI Celera Cytogenetic Map 19 C3 NCBI cM Map 19 38.16 NCBI
Sema4g (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955485 9,201,078 - 9,214,492 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955485 9,201,078 - 9,211,100 (-) NCBI ChiLan1.0 ChiLan1.0
SEMA4G (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 8 112,854,539 - 112,870,665 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 10 112,859,859 - 112,875,985 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 10 97,570,754 - 97,586,887 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 10 101,047,079 - 101,063,172 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 10 101,047,088 - 101,063,172 (+) Ensembl panpan1.1 panPan2
SEMA4G (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 28 13,659,541 - 13,673,807 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 28 13,662,686 - 13,672,359 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 28 13,829,017 - 13,843,309 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 28 14,127,615 - 14,141,909 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 28 14,127,665 - 14,141,907 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 28 13,673,360 - 13,687,654 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 28 13,714,650 - 13,728,945 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 28 13,846,625 - 13,860,915 (+) NCBI UU_Cfam_GSD_1.0
Sema4g (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 33,095,527 - 33,109,139 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936600 4,700,239 - 4,708,675 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936600 4,698,752 - 4,712,309 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SEMA4G (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 112,057,002 - 112,068,251 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 112,051,125 - 112,068,253 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 121,660,957 - 121,674,464 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SEMA4G (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 9 93,984,725 - 94,004,253 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 9 93,988,085 - 94,002,770 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 55,039,673 - 55,055,847 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Sema4g (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 237 Count of miRNA genes: 143 Interacting mature miRNAs: 185 Transcripts: ENSRNOT00000019956 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 631690 Scl5 Serum cholesterol level QTL 5 2.1 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 1 236125214 260522016 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2293674 Bss39 Bone structure and strength QTL 39 7.1 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 1 201554356 246554356 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 61327 Eae7 Experimental allergic encephalomyelitis QTL 7 5.6 body mass (VT:0001259) change in body weight (CMO:0002045) 1 216255568 260522016 Rat 1600392 Bw123 Body weight QTL 123 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 223201027 260522016 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 631837 Niddm35 Non-insulin dependent diabetes mellitus QTL 35 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 238699859 259647894 Rat 1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 2.2 uterus morphology trait (VT:0001120) percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759) 1 206081677 251081677 Rat 631836 Stl31 Serum triglyceride level QTL 31 4.64 5e-06 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 1 237147813 260522016 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 2293694 Bss38 Bone structure and strength QTL 38 7.05 0.0001 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 1 201554356 246554356 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 1300108 Rf8 Renal function QTL 8 3.75 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 1 228581588 259647894 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 body mass (VT:0001259) body weight (CMO:0000012) 1 224054293 260122809 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631215 Stl8 Serum triglyceride level QTL 8 9.27 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 1 225126575 260522016 Rat 631843 Bw116 Body weight QTL 116 4.1 0.016 abdominal adipose amount (VT:1000220) abdominal fat pad weight (CMO:0000088) 1 224054293 260122809 Rat 2300175 Bmd40 Bone mineral density QTL 40 15.4 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 1 201554356 246554356 Rat 731175 Uae20 Urinary albumin excretion QTL 20 3.5 0.0018 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 221264111 259647894 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 724538 Kidm1 Kidney mass QTL 1 3.2 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 213707201 252085212 Rat 2293655 Bss36 Bone structure and strength QTL 36 10.66 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 201554356 246554356 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 body mass (VT:0001259) body weight (CMO:0000012) 1 224569538 260122809 Rat 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 body mass (VT:0001259) body weight (CMO:0000012) 1 213843987 258843987 Rat 1358890 Bp259 Blood pressure QTL 259 3.06 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 210702053 260522016 Rat 724533 Rf51 Renal function QTL 51 5.3 0.0002 kidney plasma flow trait (VT:0005524) renal plasma flow (CMO:0001914) 1 218753816 256448513 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 199050459 259647894 Rat 1549910 Bw54 Body weight QTL 54 0.05 body mass (VT:0001259) body weight (CMO:0000012) 1 214647894 259647894 Rat 70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 3.79 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 214647894 259647894 Rat 1357399 Bw45 Body weight QTL 45 3.05 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 1 206329708 251329708 Rat 724552 Glom2 Glomerulus QTL 2 3.3 0.0001 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) 1 222363780 260522016 Rat 2316896 Gluco57 Glucose level QTL 57 7.2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 228985440 245907899 Rat 1357404 Bw42 Body weight QTL 42 4.49 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 206329708 251329708 Rat 10053715 Scort24 Serum corticosterone level QTL 24 2.13 0.0088 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 221414816 260522016 Rat 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 11 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 218753689 245907899 Rat 10059587 Bw173 Body weight QTL 173 3.23 0.025 body mass (VT:0001259) body weight (CMO:0000012) 1 202069611 247069611 Rat 2292216 Bw80 Body weight QTL 80 3.23 0.0019 body mass (VT:0001259) body weight (CMO:0000012) 1 213533809 243914901 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 7387289 Uae45 Urinary albumin excretion QTL 45 2.86 0.0021 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 223262787 260522016 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 1581544 Rf52 Renal function QTL 52 0.05 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 1 232156370 259647894 Rat 1600363 Hc6 Hypercalciuria QTL 6 2.7 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 203995416 244113296 Rat 631536 Lnnr2 Liver neoplastic nodule remodeling QTL 2 2.9 0.0005 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705) 1 233948574 260522016 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 2302040 Pia35 Pristane induced arthritis QTL 35 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 216255568 260522016 Rat 631669 Iddm9 Insulin dependent diabetes mellitus QTL 9 2.8 0.039 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 233190394 258625266 Rat 7394701 Uae46 Urinary albumin excretion QTL 46 3.6 0.0056 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 201554356 246554356 Rat 1598821 Rf55 Renal function QTL 55 6.3 renal blood flow trait (VT:2000006) ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239) 1 218748008 257976495 Rat
AI507908
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 243,865,092 - 243,865,180 (+) MAPPER mRatBN7.2 Rnor_6.0 1 264,753,149 - 264,753,236 NCBI Rnor6.0 Rnor_5.0 1 272,195,537 - 272,195,624 UniSTS Rnor5.0 RGSC_v3.4 1 250,068,742 - 250,068,829 UniSTS RGSC3.4 Celera 1 239,676,571 - 239,676,658 UniSTS Cytogenetic Map 1 q54 UniSTS
AW554132
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 243,864,851 - 243,864,936 (+) MAPPER mRatBN7.2 Rnor_6.0 1 264,752,908 - 264,752,992 NCBI Rnor6.0 Rnor_5.0 1 272,195,296 - 272,195,380 UniSTS Rnor5.0 RGSC_v3.4 1 250,068,501 - 250,068,585 UniSTS RGSC3.4 Celera 1 239,676,330 - 239,676,414 UniSTS Cytogenetic Map 1 q54 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000019956 ⟹ ENSRNOP00000019956
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 243,853,854 - 243,865,341 (+) Ensembl Rnor_6.0 Ensembl 1 264,741,911 - 264,753,397 (+) Ensembl
RefSeq Acc Id:
NM_001108526 ⟹ NP_001101996
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 253,803,016 - 253,814,502 (+) NCBI mRatBN7.2 1 243,853,854 - 243,865,341 (+) NCBI Rnor_6.0 1 264,741,911 - 264,753,397 (+) NCBI Rnor_5.0 1 272,181,343 - 272,195,787 (+) NCBI RGSC_v3.4 1 250,057,504 - 250,068,990 (+) RGD Celera 1 239,665,332 - 239,676,819 (+) RGD
Sequence:
AGAGAACAGAGAACTGGAACTTGCCCTGAAGTTGGGGGCAAGGTGACCCCTTCAGTACCCTACAATTCTGCTGGGATCCTACAATTCCCACTCTCCATGGATTTGATACAGAAAGGCACGTGACCCAC CCCTCCCTCCGACTTCTCACCTGTGATTCCATGGCCACACAACCCTGTGGCTCCATGTCCCCGCCATTCCAGGATCCTCCATGGCCCCATGACTACTTGACCCCCATGACCTCATGACCCCTCACCTC CATGTGATCACACCCTGGACTTTGAACCCAGTGACTGATCTTCCCCTCCCCTCCTGTGACTCTTCCGGGCTGCCCTTGGGGTCTTGTTGGTCTGAACTTCCCCAGGAAGATGTGGGGGAGGCTCTGGC CCCTCCTCTTCAGCTTCCTCACAGCAACAGCAGTGCCTGGACCCTCACTGCGGAGACCATCCCGAGAGCTAGATGCCACCCCACGGATGACCATCTCCTATGAAGAGCTCTCCTGGATCAGGCACTTC AAGGGCCAAGCCCAGAACTATTCAACACTGCTGCTGGAGGAGGCTTCCCAAAGGCTGTTGGTGGGAGCTCGAGGTGCCCTGTTCTCTCTCAGTGCCCGTGACATAGGAGATGGGACTCACAAAGAGAT CCACTGGGAGGCCTCCCCAGAGATGCAAAGCAAGTGTCATCAGAAAGGGAAAAACAACCAGACGGAGTGTTTCAACCATGTGCGATTTCTACAGCGGCTCAATGCCTCCCACTTCTATGCATGTGGGA CCCACGCCTTCCAGCCCCTCTGTGCAGCCATTGATGCTGAGGCCTTCATCTTGCCTACTAGCTTCGAGGAGGGAAAGGAGAAATGTCCTTACGACCCAGCCCGTGGCTTCACGGGCCTTATCATTGAT GGAGGCCTCTACACAGCCACGCGGTATGAATTCCGGAGCATTCCTGATATCCGCCGGAGCCGCCACCCACACTCTCTGAGAACCGAGGAGGCACCCATGCACTGGCTCAATGATGCTGAGTTTGTGTT CTCTGTGCTGGTGCGGGAGAGCAAGACCAGTGTAGTGGGTGACGATGACAAGATTTACTACTTCTTCATGGAGCGTGAGGAAGGTTCCAGCAGCTTCACTCAGAGTCGCAGCAGCCACCGTGTGGCTA GAGTAGCCCGTGTGTGCAAGGGAGATCTGGGAGGGAAGAAGATCCTACAGAAGAAGTGGACATCCTTCCTGAAGGCTCGCCTCATCTGCCACATCCCACAGTATGAGACACTTCGTGGGGTCTGCAGC CTGGATGCTGATACGTCATCCCACACACACTTCTATGCAGTCTTCACACTGACGACACAGTGGAAGACTCTGGAGGCTTCAGCCATCTGCCGCTATGACCTGGCTGAGATTCAGGCTGTCTTCACAGG CCCTTTTATGGAGTACCAGGATGGTGCCCGGCGCTGGGGCCGCTACGAGGGTGGAGTCCCTGAACCCAGGCCTGGCTCGTGCATCACAGATTCATTGCGCAGCCGAGGCTACAACTCATCTCAAGACT TGCCATCCCTCGTTCTGGACTTTGTGAAGTTGCACCCACTGATGGCTCGGCCTGTGGTACCCACACGTGGGCGGCCCCTGCTGCTGAAGCGCAATGTACGCTACACACATCTCACAGGAACACACGTC AGCATACCTGCTGGACCCACCTATGACCTGCTCTTTCTAGGCACAGCTGATGGCTGGATCCACAAGGCCGTAGTCCTGGGCTCTGGGATGCACATTATCGAAGAGATACAAGTGTTCAGGGAGTCCCA GTCTGTGGACAATCTAGTTATCTCACCGATGCAGCACAGCCTCTATGTGGGGGCTGCGAGTGGAGTCATCCAGTTTCCTCTGTCCAGTTGCTCACGCTACCGTTCCTGCTATGACTGCATCCTGGCAC GGGACCCCTACTGTGGCTGGGACTCCAGCACCCATGCCTGCATGGTGGCCACCACCATAGCCAACAGGACAGCATTGATACAGGACATAGAGAGAGGAAATCGAGGCTGTGAGGGCAGCAGGGATGCA GGACCACCACCGCCATTCAAGACCCGATCTGTGCTCCGGGGTGATGATGTCCTCTTGCCCTGTGACCAGCCATCTAACCTGGCCCGGGCTTTGTGGCTCCTCAACGGGAGCAAGAGCCTGAGTGATGG GCAGGATGGCTACCGCGTGGGAGTGGATGGGCTGCTGGTAACAGACACACAACTGGAGCATAGTGGCAACTATGGCTGCTATGCTGAGGAGAACGGCCTCCGTATGCTGCTGGCTTCCTACAGCCTCA TAGTCCGGCCAGCCACCCCTGCCCCAGCTCCACAAGCCCCTGCCACACCTGGGGCACAGCTGGCACATGACATGAGATTGTTCTATGTGGTAGCCATTGCTATACTTGGTGGCCTCTGCCTTATCTTG GCATCTTCCCTCCTCTATGTGGCTTGTCTGCGGGGAGGCAGACGAGGTCGAAGACGAAAATACTCATTGGGTCGGGCTGGCCGGGCAGGGGGCTCAGCCGTGCAGCTGCAGACTGTCTCAGGCCAGTG TCCCGGAGAGGAAGATGACGGTGATGATGGAGAAGGCGCTGGCAGTCTGGAGAGTGGCTGCCTCCAGATCATCCCTGGGGAAGGAGCCCCAGCCCCACCACCCCCACCACCTCCACCCCCACCTGCTG AGCTGACCAATGGACTGGTGGCCCTGCCCAGCCGGCTGCGAAGGATGAATGGCAACAGTTACGTGCTCCTGAGGCAGAGCAACAATGGAGTGCCAGCAGGTCCCTGCTCCTTTGCAGAGGAGCTCAGC CGCATCCTGGAGAAGAGGAAGCACACGCAGCTTGTAGAGCAGCTAGATGAGAGCTCTGTTTGAACCTAGCCTCCTAAACAAATGCTCTTCCAAGCCAGCCTGTCTGCCCTAGGCGGGGCCACTGCCTC CCCAAACATCCACTCTCCTTCTTGCTCCCAACTCCATTTCCTTCTTCCAACTTTTTGATGTCTCTGTAGGGCTGGCCAGAGTCATGGTTAGCCAAAGTCCCCTCTTCAGTCTCCAAGACACATGTGAG CAGCCCAGACCCACCGGTGCTCCTCAAAGGTAGGTGCTCCCCAGAACCAAGTACTCCGCAAACCCAGACCCAGTTTCTGTCCCTTGACCTAAAGACTTGGGAGGAGAGGATTGTCTTCTTATCCCATT ATCTGTCCAACCTTCCTCTTCTTCTCAGGTAGGGCTCTGCAGGTCCAGATGGCCTCAATGTCACCACCCTCTGCACAGCTGTGTGCTGGGTAGTCCTGAATTCAGACAAGACCTCTCTCTACCAGCCA CCTGAGTCCTGCTTCCATTCCCATGTGCACATGGAAGAATGTTTATCAGCTGGGCTGCAGTGTCCCGCTCCTCCTCTTGGGGCATCCTTGTCTCACTCCTCCTAGATTCAGGGCACCTTCCAATTGTC ACCTTCCTATCTAGTCCTCTTCAGTCCCAGCCCCATGTGGTAACCCTTTGGCAGGAGTCAGGGAACAGGCCGGCTTGGGAGGAAAGAAGCATCACTCCTCTCTTCTTTCCTCTGTAACCCTTGTGAGT CAGCCTCCCTCCTCCTCTCATTCACATGCAAGGGTGCCAGAGCTCCAGGCATGTCCTTTTCTTGTGCATATGTGGCAACACATCCACGTCATGTGCTGACATTTCCACCCACATGTACATTCTGAACC TCCCCTTGCTGCCTCAGTCAGACCTCTGTCTACTGGGCTTGGTCCATGGATATTTCAAAGGGAGATTTCCCTTCCCATTTAGCTGTCCTCACTGAACTAGGACAAGTGGCCAACACTGCACTCAATGA GCCAGCCTCCCTCTTAGGGACCAAGCAATTGCTTCTCCTAGACCAGAGCAGGAGGAAGTGATCTGTTATCTCACCTGGCACATGAAGCCCATTCCTGGAACTATGCAAAGGGCAGAGGCTGGGAGTTT GGATGCTTGGCTCCCATTCCTGTCCTACCTCACCAGGGCACTTTCAAGGTCCAGGGCCTCAGATGTCTCCAGGCCCATATGGGACAATCAACCCTGACTGAGCTCTCCCATTCCCCTTGGGTGAGGAT GACTGTTATTTTTGTAGCTGAGAACGTGGAACCCCACGAGTTTTTACTGCCCTTCACCCATACCTCTCCCACCTCCACCCCACAATGAATGTATTTATTGTGAGAATGGCTGTACTTCTTCAGGAATG CCCCCCACTCATCACCCAGGTGGGTGGAGCAGGCATGTGATGGAATGGGGAGCCTGGGCTCTGCTCCTCCTGATGTTGGCTAATAAATGCCCTCTTTCCCCA
hide sequence
RefSeq Acc Id:
XM_006231528 ⟹ XP_006231590
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 253,799,552 - 253,814,504 (+) NCBI mRatBN7.2 1 243,849,979 - 243,865,343 (+) NCBI Rnor_6.0 1 264,738,935 - 264,753,399 (+) NCBI Rnor_5.0 1 272,181,343 - 272,195,787 (+) NCBI
Sequence:
CCCGCCCCACCCTCGGCTCCGCCTCCACCCCGCCTCGCTCCGGCCGCGGCCCCTTCCTCCCGCAGCTGGTGCCGTGGGGCCGCGGAGCCGCACATCGCTGTCTTCATGGGCCCGGATCCCAGCGCAAA GAGAACAGAGAACTGGAACTTGCCCTGAAGTTGGGGGCAAGGTGACCCCTTCAGTACCCTACAATTCTGCTGGGATCCTACAATTCCCACTCTCCATGGATTTGATACAGAAAGGCACGTGACCCACC CCTCCCTCCGACTTCTCACCTGTGATTCCATGGCCACACAACCCTGTGGCTCCATGTCCCCGCCATTCCAGGATCCTCCATGGCCCCATGACTACTTGACCCCCATGACCTCATGACCCCTCACCTCC ATGTGATCACACCCTGGACTTTGAACCCAGTGACTGATCTTCCCCTCCCCTCCTGTGACTCTTCCGGGCTGCCCTTGGGGTCTTGTTGGTCTGAACTTCCCCAGGAAGATGTGGGGGAGGCTCTGGCC CCTCCTCTTCAGCTTCCTCACAGCAACAGCAGTGCCTGGACCCTCACTGCGGAGACCATCCCGAGAGCTAGATGCCACCCCACGGATGACCATCTCCTATGAAGAGCTCTCCTGGATCAGGCACTTCA AGGGCCAAGCCCAGAACTATTCAACACTGCTGCTGGAGGAGGCTTCCCAAAGGCTGTTGGTGGGAGCTCGAGGTGCCCTGTTCTCTCTCAGTGCCCGTGACATAGGAGATGGGACTCACAAAGAGATC CACTGGGAGGCCTCCCCAGAGATGCAAAGCAAGTGTCATCAGAAAGGGAAAAACAACCAGACGGAGTGTTTCAACCATGTGCGATTTCTACAGCGGCTCAATGCCTCCCACTTCTATGCATGTGGGAC CCACGCCTTCCAGCCCCTCTGTGCAGCCATTGATGCTGAGGCCTTCATCTTGCCTACTAGCTTCGAGGAGGGAAAGGAGAAATGTCCTTACGACCCAGCCCGTGGCTTCACGGGCCTTATCATTGATG GAGGCCTCTACACAGCCACGCGGTATGAATTCCGGAGCATTCCTGATATCCGCCGGAGCCGCCACCCACACTCTCTGAGAACCGAGGAGGCACCCATGCACTGGCTCAATGATGCTGAGTTTGTGTTC TCTGTGCTGGTGCGGGAGAGCAAGACCAGTGTAGTGGGTGACGATGACAAGATTTACTACTTCTTCATGGAGCGTGAGGAAGGTTCCAGCAGCTTCACTCAGAGTCGCAGCAGCCACCGTGTGGCTAG AGTAGCCCGTGTGTGCAAGGGAGATCTGGGAGGGAAGAAGATCCTACAGAAGAAGTGGACATCCTTCCTGAAGGCTCGCCTCATCTGCCACATCCCACAGTATGAGACACTTCGTGGGGTCTGCAGCC TGGATGCTGATACGTCATCCCACACACACTTCTATGCAGTCTTCACACTGACGACACAGTGGAAGACTCTGGAGGCTTCAGCCATCTGCCGCTATGACCTGGCTGAGATTCAGGCTGTCTTCACAGGC CCTTTTATGGAGTACCAGGATGGTGCCCGGCGCTGGGGCCGCTACGAGGGTGGAGTCCCTGAACCCAGGCCTGGCTCGTGCATCACAGATTCATTGCGCAGCCGAGGCTACAACTCATCTCAAGACTT GCCATCCCTCGTTCTGGACTTTGTGAAGTTGCACCCACTGATGGCTCGGCCTGTGGTACCCACACGTGGGCGGCCCCTGCTGCTGAAGCGCAATGTACGCTACACACATCTCACAGGAACACACGTCA GCATACCTGCTGGACCCACCTATGACCTGCTCTTTCTAGGCACAGCTGATGGCTGGATCCACAAGGCCGTAGTCCTGGGCTCTGGGATGCACATTATCGAAGAGATACAAGTGTTCAGGGAGTCCCAG TCTGTGGACAATCTAGTTATCTCACCGATGCAGCACAGCCTCTATGTGGGGGCTGCGAGTGGAGTCATCCAGTTTCCTCTGTCCAGTTGCTCACGCTACCGTTCCTGCTATGACTGCATCCTGGCACG GGACCCCTACTGTGGCTGGGACTCCAGCACCCATGCCTGCATGGTGGCCACCACCATAGCCAACAGGACAGCATTGATACAGGACATAGAGAGAGGAAATCGAGGCTGTGAGGGCAGCAGGGATGCAG GACCACCACCGCCATTCAAGACCCGATCTGTGCTCCGGGGTGATGATGTCCTCTTGCCCTGTGACCAGCCATCTAACCTGGCCCGGGCTTTGTGGCTCCTCAACGGGAGCAAGAGCCTGAGTGATGGG CAGGATGGCTACCGCGTGGGAGTGGATGGGCTGCTGGTAACAGACACACAACTGGAGCATAGTGGCAACTATGGCTGCTATGCTGAGGAGAACGGCCTCCGTATGCTGCTGGCTTCCTACAGCCTCAT AGTCCGGCCAGCCACCCCTGCCCCAGCTCCACAAGCCCCTGCCACACCTGGGGCACAGCTGGCACATGACATGAGATTGTTCTATGTGGTAGCCATTGCTATACTTGGTGGCCTCTGCCTTATCTTGG CATCTTCCCTCCTCTATGTGGCTTGTCTGCGGGGAGGCAGACGAGGTCGAAGACGAAAATACTCATTGGGTCGGGCTGGCCGGGCAGGGGGCTCAGCCGTGCAGCTGCAGACTGTCTCAGGCCAGTGT CCCGGAGAGGAAGATGACGGTGATGATGGAGAAGGCGCTGGCAGTCTGGAGAGTGGCTGCCTCCAGATCATCCCTGGGGAAGGAGCCCCAGCCCCACCACCCCCACCACCTCCACCCCCACCTGCTGA GCTGACCAATGGACTGGTGGCCCTGCCCAGCCGGCTGCGAAGGATGAATGGCAACAGTTACGTGCTCCTGAGGCAGAGCAACAATGGAGTGCCAGCAGGTCCCTGCTCCTTTGCAGAGGAGCTCAGCC GCATCCTGGAGAAGAGGAAGCACACGCAGCTTGTAGAGCAGCTAGATGAGAGCTCTGTTTGAACCTAGCCTCCTAAACAAATGCTCTTCCAAGCCAGCCTGTCTGCCCTAGGCGGGGCCACTGCCTCC CCAAACATCCACTCTCCTTCTTGCTCCCAACTCCATTTCCTTCTTCCAACTTTTTGATGTCTCTGTAGGGCTGGCCAGAGTCATGGTTAGCCAAAGTCCCCTCTTCAGTCTCCAAGACACATGTGAGC AGCCCAGACCCACCGGTGCTCCTCAAAGGTAGGTGCTCCCCAGAACCAAGTACTCCGCAAACCCAGACCCAGTTTCTGTCCCTTGACCTAAAGACTTGGGAGGAGAGGATTGTCTTCTTATCCCATTA TCTGTCCAACCTTCCTCTTCTTCTCAGGTAGGGCTCTGCAGGTCCAGATGGCCTCAATGTCACCACCCTCTGCACAGCTGTGTGCTGGGTAGTCCTGAATTCAGACAAGACCTCTCTCTACCAGCCAC CTGAGTCCTGCTTCCATTCCCATGTGCACATGGAAGAATGTTTATCAGCTGGGCTGCAGTGTCCCGCTCCTCCTCTTGGGGCATCCTTGTCTCACTCCTCCTAGATTCAGGGCACCTTCCAATTGTCA CCTTCCTATCTAGTCCTCTTCAGTCCCAGCCCCATGTGGTAACCCTTTGGCAGGAGTCAGGGAACAGGCCGGCTTGGGAGGAAAGAAGCATCACTCCTCTCTTCTTTCCTCTGTAACCCTTGTGAGTC AGCCTCCCTCCTCCTCTCATTCACATGCAAGGGTGCCAGAGCTCCAGGCATGTCCTTTTCTTGTGCATATGTGGCAACACATCCACGTCATGTGCTGACATTTCCACCCACATGTACATTCTGAACCT CCCCTTGCTGCCTCAGTCAGACCTCTGTCTACTGGGCTTGGTCCATGGATATTTCAAAGGGAGATTTCCCTTCCCATTTAGCTGTCCTCACTGAACTAGGACAAGTGGCCAACACTGCACTCAATGAG CCAGCCTCCCTCTTAGGGACCAAGCAATTGCTTCTCCTAGACCAGAGCAGGAGGAAGTGATCTGTTATCTCACCTGGCACATGAAGCCCATTCCTGGAACTATGCAAAGGGCAGAGGCTGGGAGTTTG GATGCTTGGCTCCCATTCCTGTCCTACCTCACCAGGGCACTTTCAAGGTCCAGGGCCTCAGATGTCTCCAGGCCCATATGGGACAATCAACCCTGACTGAGCTCTCCCATTCCCCTTGGGTGAGGATG ACTGTTATTTTTGTAGCTGAGAACGTGGAACCCCACGAGTTTTTACTGCCCTTCACCCATACCTCTCCCACCTCCACCCCACAATGAATGTATTTATTGTGAGAATGGCTGTACTTCTTCAGGAATGC CCCCCACTCATCACCCAGGTGGGTGGAGCAGGCATGTGATGGAATGGGGAGCCTGGGCTCTGCTCCTCCTGATGTTGGCTAATAAATGCCCTCTTTCCCCACA
hide sequence
RefSeq Acc Id:
XR_351089
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 253,799,552 - 253,814,504 (+) NCBI mRatBN7.2 1 243,849,979 - 243,865,343 (+) NCBI Rnor_6.0 1 264,738,935 - 264,753,399 (+) NCBI Rnor_5.0 1 272,181,343 - 272,195,787 (+) NCBI
Sequence:
CCCGCCCCACCCTCGGCTCCGCCTCCACCCCGCCTCGCTCCGGCCGCGGCCCCTTCCTCCCGCAGCTGGTGCCGTGGGGCCGCGGAGCCGCACATCGCTGTCTTCATGGGCCCGGATCCCAGCGCAAA GAGAACAGAGAACTGGAACTTGCCCTGAAGTTGGGGGCAAGGTGACCCCTTCAGTACCCTACAATTCTGCTGGGATCCTACAATTCCCACTCTCCATGGATTTGATACAGAAAGGCACGTGACCCACC CCTCCCTCCGACTTCTCACCTGTGATTCCATGGCCACACAACCCTGTGGCTCCATGTCCCCGCCATTCCAGGATCCTCCATGGCCCCATGACTACTTGACCCCCATGACCTCATGACCCCTCACCTCC ATGTGATCACACCCTGGACTTTGAACCCAGTGACTGATCTTCCCCTCCCCTCCTGTGACTCTTCCGGGCTGCCCTTGGGGTCTTGTTGGTCTGAACTTCCCCAGGAAGATGTGGGGGAGGCTCTGGCC CCTCCTCTTCAGCTTCCTCACAGCAACAGCAGTGCCTGGACCCTCACTGCGGAGACCATCCCGAGAGCTAGATGCCACCCCACGGATGACCATCTCCTATGAAGAGCTCTCCTGGATCAGGCACTTCA AGGGCCAAGCCCAGAACTATTCAACACTGCTGCTGGAGGAGGCTTCCCAAAGGCTGTTGGTGGGAGCTCGAGGTGCCCTGTTCTCTCTCAGTGCCCGTGACATAGGAGATGGGACTCACAAAGAGATC CACTGGGAGGCCTCCCCAGAGATGCAAAGCAAGTGTCATCAGAAAGGGAAAAACAACCAGACGGAGTGTTTCAACCATGTGCGATTTCTACAGCGGCTCAATGCCTCCCACTTCTATGCATGTGGGAC CCACGCCTTCCAGCCCCTCTGTGCAGCCATTGATGCTGAGGCCTTCATCTTGCCTACTAGCTTCGAGGAGGGAAAGGAGAAATGTCCTTACGACCCAGCCCGTGGCTTCACGGGCCTTATCATTGATG GAGGCCTCTACACAGCCACGCGGTATGAATTCCGGAGCATTCCTGATATCCGCCGGAGCCGCCACCCACACTCTCTGAGAACCGAGGAGGCACCCATGCACTGGCTCAATGATGCTGAGTTTGTGTTC TCTGTGCTGGTGCGGGAGAGCAAGACCAGTGTAGTGGGTGACGATGACAAGATTTACTACTTCTTCATGGAGCGTGAGGAAGGTTCCAGCAGCTTCACTCAGAGTCGCAGCAGCCACCGTGTGGCTAG AGTAGCCCGTGTGTGCAAGGGAGATCTGGGAGGGAAGAAGATCCTACAGAAGAAGTGGACATCCTTCCTGAAGGCTCGCCTCATCTGCCACATCCCACAGTATGAGACACTTCGTGGGGTCTGCAGCC TGGATGCTGATACGTCATCCCACACACACTTCTATGCAGTCTTCACACTGACGACACAGTGGAAGACTCTGGAGGCTTCAGCCATCTGCCGCTATGACCTGGCTGAGATTCAGGCTGTCTTCACAGGC CCTTTTATGGAGTACCAGGATGGTGCCCGGCGCTGGGGCCGCTACGAGGGTGGAGTCCCTGAACCCAGGCCTGGCTCGTGCATCACAGATTCATTGCGCAGCCGAGGCTACAACTCATCTCAAGACTT GCCATCCCTCGTTCTGGACTTTGTGAAGTTGCACCCACTGATGGCTCGGCCTGTGGTACCCACACGTGGGCGGCCCCTGCTGCTGAAGCGCAATGTACGCTACACACATCTCACAGGAACACACGTCA GCATACCTGCTGGACCCACCTATGACCTGCTCTTTCTAGGCACAGCTGATGGCTGGATCCACAAGGCCGTAGTCCTGGGCTCTGGGATGCACATTATCGAAGAGATACAAGTGTTCAGGGAGTCCCAG TCTGTGGACAATCTAGTTATCTCACCGATGCAGCACAGCCTCTATGTGGGGGCTGCGAGTGGAGTCATCCAGTTTCCTCTGTCCAGTTGCTCACGCTACCGTTCCTGCTATGACTGCATCCTGGCACG GGACCCCTACTGTGGCTGGGACTCCAGCACCCATGCCTGCATGGTGGCCACCACCATAGCCAACAGGACAGCATTGATACAGGACATAGAGAGAGGAAATCGAGGCTGTGAGGGCAGCAGGGATGCAG GACCACCACCGCCATTCAAGACCCGATCTGTGCTCCGGGGTGATGATGTCCTCTTGCCCTGTGACCAGCCATCTAACCTGGCCCGGGCTTTGTGGCTCCTCAACGGGAGCAAGAGCCTGAGTGATGGG CAGGATGGCTACCGCGTGGGAGTGGATGGGCTGCTGGTAACAGACACACAACTGGAGCATAGTGGCAACTATGGCTGCTATGCTGAGGAGAACGGCCTCCGTATGCTGCTGGCTTCCTACAGCCTCAT AGTCCGGCCAGCCACCCCTGCCCCAGCTCCACAAGCCCCTGCCACACCTGGGGCACAGCTGGCACATGACATGAGATTGTTCTATGTGGTAGCCATTGCTATACTTGGTGGCCTCTGCCTTATCTTGG CATCTTCCCTCCTCTATGTGGCTTGTCTGCGGGGAGGCAGACGAGGTCGAAGACGAAAATACTCATTGGGTCGGGCTGGCCGGGCAGGGGGCTCAGCCGTGCAGCTGCAGACTGTCTCAGGCCAGTGT CCCGGAGAGGAAGATGACGGTGATGATGGAGAAGGCGCTGGCAGTCTGGAGAGTGGCTGCCTCCAGATCATCCCTGGGGAAGGAGCCCCAGCCCCACCACCCCCACCACCTCCACCCCCACCTGCTGA GCTGACCAATGGACTGGTGGCCCTGCCCAGCCGGCTGCGAAGGATGAATGGCAACAGTTACGTGCTCCTGAGGCAGAGCAACAATGGAGTGCCAGCAGGTCCCTGCTCCTTTGCAGAGGAGCTCAGCC GCATCCTGGAGAAGAGGAAGCACACGCAGCTTGTAGAGCAGCTAGATGAGAGCTCTGTTTGAACCTAGCCTCCTAAACAAATGCTCTTCCAAGCCAGCCTGTCTGCCCTAGGCGGGGCCACTGCCTCC CCAAACATCCACTCTCCTTCTTGCTCCCAACTCCATTTCCTTCTTCCAACTTTTTGATGTCTCTGTAGGGCTGGCCAGAGTCATGGTTAGCCAAAGTCCCCTCTTCAGTCTCCAAGACACATGTGAGC AGCCCAGACCCACCGGTGCTCCTCAAAGGTAGGGCTCTGCAGGTCCAGATGGCCTCAATGTCACCACCCTCTGCACAGCTGTGTGCTGGGTAGTCCTGAATTCAGACAAGACCTCTCTCTACCAGCCA CCTGAGTCCTGCTTCCATTCCCATGTGCACATGGAAGAATGTTTATCAGCTGGGCTGCAGTGTCCCGCTCCTCCTCTTGGGGCATCCTTGTCTCACTCCTCCTAGATTCAGGGCACCTTCCAATTGTC ACCTTCCTATCTAGTCCTCTTCAGTCCCAGCCCCATGTGGTAACCCTTTGGCAGGAGTCAGGGAACAGGCCGGCTTGGGAGGAAAGAAGCATCACTCCTCTCTTCTTTCCTCTGTAACCCTTGTGAGT CAGCCTCCCTCCTCCTCTCATTCACATGCAAGGGTGCCAGAGCTCCAGGCATGTCCTTTTCTTGTGCATATGTGGCAACACATCCACGTCATGTGCTGACATTTCCACCCACATGTACATTCTGAACC TCCCCTTGCTGCCTCAGTCAGACCTCTGTCTACTGGGCTTGGTCCATGGATATTTCAAAGGGAGATTTCCCTTCCCATTTAGCTGTCCTCACTGAACTAGGACAAGTGGCCAACACTGCACTCAATGA GCCAGCCTCCCTCTTAGGGACCAAGCAATTGCTTCTCCTAGACCAGAGCAGGAGGAAGTGATCTGTTATCTCACCTGGCACATGAAGCCCATTCCTGGAACTATGCAAAGGGCAGAGGCTGGGAGTTT GGATGCTTGGCTCCCATTCCTGTCCTACCTCACCAGGGCACTTTCAAGGTCCAGGGCCTCAGATGTCTCCAGGCCCATATGGGACAATCAACCCTGACTGAGCTCTCCCATTCCCCTTGGGTGAGGAT GACTGTTATTTTTGTAGCTGAGAACGTGGAACCCCACGAGTTTTTACTGCCCTTCACCCATACCTCTCCCACCTCCACCCCACAATGAATGTATTTATTGTGAGAATGGCTGTACTTCTTCAGGAATG CCCCCCACTCATCACCCAGGTGGGTGGAGCAGGCATGTGATGGAATGGGGAGCCTGGGCTCTGCTCCTCCTGATGTTGGCTAATAAATGCCCTCTTTCCCCACA
hide sequence
RefSeq Acc Id:
NP_001101996 ⟸ NM_001108526
- Peptide Label:
precursor
- UniProtKB:
D4A6G2 (UniProtKB/TrEMBL), A6JHH1 (UniProtKB/TrEMBL)
- Sequence:
MWGRLWPLLFSFLTATAVPGPSLRRPSRELDATPRMTISYEELSWIRHFKGQAQNYSTLLLEEASQRLLVGARGALFSLSARDIGDGTHKEIHWEASPEMQSKCHQKGKNNQTECFNHVRFLQRLNAS HFYACGTHAFQPLCAAIDAEAFILPTSFEEGKEKCPYDPARGFTGLIIDGGLYTATRYEFRSIPDIRRSRHPHSLRTEEAPMHWLNDAEFVFSVLVRESKTSVVGDDDKIYYFFMEREEGSSSFTQSR SSHRVARVARVCKGDLGGKKILQKKWTSFLKARLICHIPQYETLRGVCSLDADTSSHTHFYAVFTLTTQWKTLEASAICRYDLAEIQAVFTGPFMEYQDGARRWGRYEGGVPEPRPGSCITDSLRSRG YNSSQDLPSLVLDFVKLHPLMARPVVPTRGRPLLLKRNVRYTHLTGTHVSIPAGPTYDLLFLGTADGWIHKAVVLGSGMHIIEEIQVFRESQSVDNLVISPMQHSLYVGAASGVIQFPLSSCSRYRSC YDCILARDPYCGWDSSTHACMVATTIANRTALIQDIERGNRGCEGSRDAGPPPPFKTRSVLRGDDVLLPCDQPSNLARALWLLNGSKSLSDGQDGYRVGVDGLLVTDTQLEHSGNYGCYAEENGLRML LASYSLIVRPATPAPAPQAPATPGAQLAHDMRLFYVVAIAILGGLCLILASSLLYVACLRGGRRGRRRKYSLGRAGRAGGSAVQLQTVSGQCPGEEDDGDDGEGAGSLESGCLQIIPGEGAPAPPPPP PPPPPAELTNGLVALPSRLRRMNGNSYVLLRQSNNGVPAGPCSFAEELSRILEKRKHTQLVEQLDESSV
hide sequence
RefSeq Acc Id:
XP_006231590 ⟸ XM_006231528
- Peptide Label:
isoform X1
- UniProtKB:
D4A6G2 (UniProtKB/TrEMBL), A6JHH1 (UniProtKB/TrEMBL)
- Sequence:
MWGRLWPLLFSFLTATAVPGPSLRRPSRELDATPRMTISYEELSWIRHFKGQAQNYSTLLLEEASQRLLVGARGALFSLSARDIGDGTHKEIHWEASPEMQSKCHQKGKNNQTECFNHVRFLQRLNAS HFYACGTHAFQPLCAAIDAEAFILPTSFEEGKEKCPYDPARGFTGLIIDGGLYTATRYEFRSIPDIRRSRHPHSLRTEEAPMHWLNDAEFVFSVLVRESKTSVVGDDDKIYYFFMEREEGSSSFTQSR SSHRVARVARVCKGDLGGKKILQKKWTSFLKARLICHIPQYETLRGVCSLDADTSSHTHFYAVFTLTTQWKTLEASAICRYDLAEIQAVFTGPFMEYQDGARRWGRYEGGVPEPRPGSCITDSLRSRG YNSSQDLPSLVLDFVKLHPLMARPVVPTRGRPLLLKRNVRYTHLTGTHVSIPAGPTYDLLFLGTADGWIHKAVVLGSGMHIIEEIQVFRESQSVDNLVISPMQHSLYVGAASGVIQFPLSSCSRYRSC YDCILARDPYCGWDSSTHACMVATTIANRTALIQDIERGNRGCEGSRDAGPPPPFKTRSVLRGDDVLLPCDQPSNLARALWLLNGSKSLSDGQDGYRVGVDGLLVTDTQLEHSGNYGCYAEENGLRML LASYSLIVRPATPAPAPQAPATPGAQLAHDMRLFYVVAIAILGGLCLILASSLLYVACLRGGRRGRRRKYSLGRAGRAGGSAVQLQTVSGQCPGEEDDGDDGEGAGSLESGCLQIIPGEGAPAPPPPP PPPPPAELTNGLVALPSRLRRMNGNSYVLLRQSNNGVPAGPCSFAEELSRILEKRKHTQLVEQLDESSV
hide sequence
Ensembl Acc Id:
ENSRNOP00000019956 ⟸ ENSRNOT00000019956
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-01-21
Sema4g
semaphorin 4G
Sema4g
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Sema4g
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
Sema4g_predicted
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Sema4g_predicted
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G (predicted)
Symbol and Name status set to approved
70820
APPROVED